EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Parathyroid carcinoma: from molecular pathogenesis to multidisciplinary management

Jia-Xi Song, Yu-Ying Yang, Jin-Xin Zhou, Jing Xie, Hao-Ji Gao, Min-Ting Zhu, Bei Tao, Xi Chen, Li-Hao Sun, Jian-Min Liu iD

The Journal of Clinical Endocrinology & Metabolism · 16.10.2026 · 111 (11) · 3012-3031

DOI: 10.1210/clinem/dgag266 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 04.07.2026. Verfasst von Jia-Xi Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong Universit…. Hauptthemen laut MEDLINE: Parathyroid Neoplasms, Carcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 139 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parathyroid carcinoma (PC) is a rare malignancy accounting for <1% of primary hyperparathyroidism cases. This review summarizes current knowledge on its molecular pathogenesis, diagnosis, imaging, management and prognosis. PC is driven primarily by CDC73 mutations with loss of parafibromin expression, with emerging roles for PI3K/AKT/mTOR and Wnt pathway alterations. Its diagnosis remains challenging. Clinical suspicion should arise with marked hypercalcemia, elevated PTH, palpable neck mass or recurrent laryngeal nerve palsy. Imaging modalities including cervical ultrasound, 99mTc-sestamibi, 4D-CT, and [18F]fluorocholine PET/CT aid localization and metastasis detection. En bloc resection with ipsilateral thyroid lobectomy is the standard approach. Traditional medical therapies are helpful in reducing serum calcium level. Radiotherapy and chemotherapy have limited efficacy. Targeted therapies and immunotherapy show promise in advanced disease, however, the such evidence is weak. Recurrence rates of 23% to 65% mandate lifelong follow-up. Prognostic factors include surgical approach, postoperative remission, Ki-67 index, as well as parafibromin status and mTOR activation. Multidisciplinary management in specialized centers is critical for optimizing outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parathyroid NeoplasmsCarcinomaHumansPrognosisTumor Suppressor Proteins

Stichwörter der Autor:innen

hypercalcemiaparathyroid carcinomaparathyroidectomyprimary hyperparathyroidism

Substanzen

CDC73 protein, humanTumor Suppressor Proteins

Autor:innen und Institutionen

  • Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, Stat…
  • Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Department of Thyroid and Vascular Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Department of General Practice, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

ORCID-Profile: Jian-Min Liu

Zitieren

APA

Song, J. X., Yang, Y. Y., Zhou, J. X., Xie, J., Gao, H. J., Zhu, M. T., Tao, B., Chen, X., Sun, L. H., & Liu, J. M. (2026). Parathyroid carcinoma: from molecular pathogenesis to multidisciplinary management. The Journal of Clinical Endocrinology & Metabolism, 111(11), 3012-3031. https://doi.org/10.1210/clinem/dgag266

Vancouver

Song JX, Yang YY, Zhou JX, Xie J, Gao HJ, Zhu MT, et al. Parathyroid carcinoma: from molecular pathogenesis to multidisciplinary management. The Journal of Clinical Endocrinology & Metabolism. 2026;111(11):3012-3031. doi:10.1210/clinem/dgag266

BibTeX
@article{Song2026,
  author = {Song, Jia-Xi and Yang, Yu-Ying and Zhou, Jin-Xin and Xie, Jing and Gao, Hao-Ji and Zhu, Min-Ting and Tao, Bei and Chen, Xi and Sun, Li-Hao and Liu, Jian-Min},
  title = {Parathyroid carcinoma: from molecular pathogenesis to multidisciplinary management},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  volume = {111},
  number = {11},
  pages = {3012--3031},
  doi = {10.1210/clinem/dgag266}
}
Kostenlos starten →